Seroprotection and improved polyfunctional immunity conferred by a YF17D-vectored rabies vaccine

Rabies remains a major public-health challenge, with pre-exposure vaccination strategies constrained by the need for multiple doses and repeated healthcare visits. Here we describe YF-RabG, a live-attenuated rabies vaccine candidate based on the yellow fever 17D (YF17D) vaccine backbone that stably expresses the rabies virus glycoprotein (RabG). YF-RabG exhibited an attenuated phenotype and favourable safety profile compared with parental YF17D across several preclinical models, including neonatal and immunocompromised mice. A single immunization induced robust humoral and cell-mediated immune responses in non-human primates. Rabies virus-neutralizing antibody titres readily exceeded the widely accepted correlate of protection in mice, hamsters and non-human primates by several orders. Accordingly, vaccination conferred protection against lethal rabies challenge in a range of stringent mouse models, maintained seroprotective antibody levels for at least one year, and increased following a boost using a licensed rabies vaccine. Furthermore, the YF17D vector was readily adapted to accommodate glycoproteins from distant lyssaviruses, generating protective vaccine candidates against Mokola, Lagos bat and Lleida bat lyssaviruses. Collectively, these findings identify YF-RabG as a promising single-dose rabies vaccine candidate and highlight the versatility of the YF17D platform for lyssavirus vaccine development.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-17
DOI
https://doi.org/10.64898/2026.11.15.766779
Primary Topic
Rabies epidemiology and control
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Seroprotection and improved polyfunctional immunity conferred by a YF17D-vectored rabies vaccine

Ernst J. Verschoor, Márta Romano, Lotte Coelmont, Corinne Vandermeulen et al.
bioRxiv (Cold Spring Harbor Laboratory)
Rabies epidemiology and control
preprint

Seroprotection and improved polyfunctional immunity conferred by a YF17D-vectored rabies vaccine

Ernst J. Verschoor, Márta Romano, Lotte Coelmont, Corinne Vandermeulen, Ashley C. Banyard, Yeranddy Aguiar Alpizar, Sanne Terryn, Anthony R. Fooks, Pieter Leyssen, Guanghui Wu, Niraj Mishra, Gerrit Koopman, Ji Ma, Lorena Sánchez-Felipe, Thomas Vercruysse, Willy M J M Bogers, Steven Van Gucht, Hendrik Jan Thibaut, Babs E. Verstrepen, Kinga P. Böszörményi, Katrien Geerts, Kai Dallmeier, Johan H. Neyts, Olivier Denis, Giresse Tima, Sarah Debayeve, Pauline Percier-Lehebel
preprint en

Abstract

Rabies remains a major public-health challenge, with pre-exposure vaccination strategies constrained by the need for multiple doses and repeated healthcare visits. Here we describe YF-RabG, a live-attenuated rabies vaccine candidate based on the yellow fever 17D (YF17D) vaccine backbone that stably expresses the rabies virus glycoprotein (RabG). YF-RabG exhibited an attenuated phenotype and favourable safety profile compared with parental YF17D across several preclinical models, including neonatal and immunocompromised mice. A single immunization induced robust humoral and cell-mediated immune responses in non-human primates. Rabies virus-neutralizing antibody titres readily exceeded the widely accepted correlate of protection in mice, hamsters and non-human primates by several orders. Accordingly, vaccination conferred protection against lethal rabies challenge in a range of stringent mouse models, maintained seroprotective antibody levels for at least one year, and increased following a boost using a licensed rabies vaccine. Furthermore, the YF17D vector was readily adapted to accommodate glycoproteins from distant lyssaviruses, generating protective vaccine candidates against Mokola, Lagos bat and Lleida bat lyssaviruses. Collectively, these findings identify YF-RabG as a promising single-dose rabies vaccine candidate and highlight the versatility of the YF17D platform for lyssavirus vaccine development.

bioRxiv (Cold Spring Harbor Laboratory)
Animal and Plant Health Agency (GB), Rega Institute for Medical Research (BE), Biomedical Primate Research Centre (NL), Institut de Recherche Vaccinale (FR), Sciensano (Belgium) (BE), KU Leuven (BE)
Good health and well-being
Rabies epidemiology and control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon